东方生物(688298.SH)子公司取得两款医疗器械产品注册证书

Core Viewpoint - The company, Dongfang Biological (688298.SH), announced that its subsidiary, Hangzhou Danwei Biotechnology Co., Ltd., has obtained registration certificates for two medical device products, enhancing its product offerings in HPV and respiratory virus detection [1] Group 1: Product Development - The two newly registered products are: a nucleic acid detection kit for 14 high-risk types of human papillomavirus (HPV) and a combined nucleic acid detection kit for COVID-19 and influenza A and B viruses, both using fluorescent PCR technology [1] - The registration of the 14 high-risk HPV nucleic acid detection kit expands the company's product range for HPV virus detection in the domestic market [1] - The COVID-19 and influenza virus detection kit enhances the company's portfolio in respiratory combined detection products, aiding in the detection of seasonal respiratory virus infections [1] Group 2: Market Expansion - The certification of these two products broadens the company's sales offerings in molecular diagnostic technology, facilitating overall market expansion in the domestic market [1]